Navigation Links
Sepsis Death Reported With Mifepristone – FDA Issues Warnin

Last Tuesday the FDA issued a public health advisory, warning physicians to watch for any signs //of sepsis or other infection among women who have taken Danco Laboratories' Mifeprex -- known generically as mifepristone -- which when taken with misoprostol can cause a medical abortion after four sepsis related deaths were reported among women who took the drug. FDA approved Mifeprex in 2000 for the termination of early pregnancy, defined as 49 or fewer days gestation.

Physicians have identified the bacterium Clostridium sordelli a common germ not usually associated with illness as the cause of two of the four deaths and suspect it as the cause of the other two deaths.

Acting director of FDA's Center for Drug Evaluation and Research, Steven Galson, said it is not clear why the bacteria became fatal in the women. He also said that the four deaths all occurred in women who did not follow FDA-approved instructions for using the drug. According to the directions, women should take both mifepristone and misoprostol orally, but some clinics instruct patients to insert misoprostol vaginally.

In the meantime the FDA has advised doctors to prescribe antibiotics immediately to women who have taken mifepristone and who have symptoms of Clostridium sordelli infection, including nausea, vomiting, diarrhea and weakness.

Danco a drug manufacturing company has said that it will revise the label of Mifeprex so as to warn users of the possibility of bacterial infection and other complications. According to Danco the Mifeprex packaging already includes a warning stating that women who use the drug could experience serious and possibly fatal infections. Danco says it also plans to send a letter to physicians and emergency department directors to inform them of the updated warning and five known deaths -- four of which were sepsis-related -- among users of Mifeprex.
'"/>




Page: 1

Related medicine news :

1. Sepsis treatment functions best in difficult cases
2. Researchers identify the early makers of Neonatal Sepsis
3. Sepsis risk increased due to the absence of one key enzyme
4. Drexel Research in Cytokines Could Treat Sepsis
5. White Cells Count Can Predict Heart Attack Death Risk
6. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
7. AIDS toll set to exceed Black Death
8. Fish Oil Fights Arrhythmias, Sudden Death
9. Painkiller Linked to Deaths
10. Death due to premature heartbeat after exercise
11. Preventing Childhood Deaths
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... Techniques.” The guide will ensure lab personnel have a basic understanding of the ... lab measurement protocols. Enhanced understanding will help them reduce waste and rework to ...
(Date:2/9/2016)... California (PRWEB) , ... February 09, 2016 , ... i2i ... one of the highest preliminary data vendors in the latest KLAS report, Population Health ... i2i has led the developing market for population health management (PHM). The latest ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... with BASF Human Nutrition into the Food & Beverage and ... been BASF’s channel partner throughout Canada and USA geographies east of the Rocky ...
(Date:2/8/2016)... ... February 08, 2016 , ... Brenton Engineering , powered ... and flow wrapped products at WestPack 2015, February 9-11, in Anaheim, California. This ... to semi-automatic or fully-automatic case packing with a small footprint, rugged, highly flexible, ...
(Date:2/8/2016)... ... 08, 2016 , ... Local insurance agency Dennis Fuller & ... has initiated a fundraiser for a two year old little girl named Bella, ... To support this beautiful child who is facing life’s journey without her loving ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... new report "Global Anti-Bacterial Drugs Market Assessment & Forecast: 2015 - ... the North America continued to lead global ... translated into revenues worth US$ 16,907.3 million. ... Asia-Pacific , Latin America , ... anti-bacterial market is inclined towards North America ...
(Date:2/8/2016)... -- Respiratory Devices - Medical Devices Pipeline Assessment, ... report, " Respiratory Devices - Medical Devices Pipeline ... Devices currently in pipeline stage. The report ... comparative analysis of the products at various stages ... in the pipeline product development. It also provides ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , Feb. 8, ... Pharmaceuticals, Inc. (Medimetriks) today announced that they have entered ... commercialization rights for OPA-15406 in the U.S. and ... manufacturing rights.  OPA-15406 is a topical, non-steroidal phosphodiesterase IV ... --> --> In ...
Breaking Medicine Technology: